Cardiac imaging for risk stratification in asymptomatic diabetes Scholte, A.J.H.A.

Hele tekst

(1)Cardiac imaging for risk stratification in asymptomatic diabetes Scholte, A.J.H.A.. Citation Scholte, A. J. H. A. (2009, November 19). Cardiac imaging for risk stratification in asymptomatic diabetes. Retrieved from https://hdl.handle.net/1887/14368 Version:. Corrected Publisher’s Version. License:. Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden. Downloaded from:. https://hdl.handle.net/1887/14368. Note: To cite this publication please use the final published version (if applicable)..

(2) Chapter. 8. Diabetic cardiovascular autonomic neuropathy by 123I

(3)

(4)

(5) variability in asymptomatic patients with type 2 diabetes mellitus

(6)

(7)

(8) !

(9) "

(10) ##$"

(11) %. &. .

(12) Chapter 8. Abstract Purpose The purpose of this study was to evaluate the prevalence of cardiac autonomic neuropa ()*+ ((,. ,/./

(13) 2 (.

(14) 3"

(15)

(16) ,

(17).

(18)

(19) $ ( )4+ " 1237!,

(20) "

(21) 8( "

(22) )123I-m79+ ,( " /.(: Methods ;; (,. ,/ ./

(23) 2 (.

(24) 3 "

(25)

(26) ,

(27). 2

(28)

(29) . .

(30) /$

(31) (

(32)

(33) " , ./

(34) "

(35)

(36) :7./

(37) 2 , ,( " .

(38) * 2

(39)

(40) " (4"123I-m79,( " /.(:2 ,

(41) ,

(42) 2

(43)

(44) "

(45) <

(46) " * . /$

(47) )#9!

(48) " " ,

(49) . (+ "

(50) .

(51) *

(52) /$

(53) :*

(54)

(55) " ( 123I-m79/.(2"

(56) <

(57) " , =

(58) >,

(59) "/,/ ?@:; 2 A3BC "

(60)

(61)

(62) A@D: Results

(63) .

(64) $

(65)

(66) *(,. ,/./

(67) 2 (.

(68) 3"

(69)

(70) " , ,( " .

(71)

(72)

(73) " (4"123I-m79/.(2

(74) .

(75) /$

(76) ( 3EC" B;C:F

(77) ,

(78) , ./

(79) 2 , 4 123I-m79/.( showed CAN. Conclusion

(80)

(81) "(

(82) $

(83)

(84) ".

(85) $

(86)

(87) *./

(88) 2 (.

(89) 3"

(90)

(91) ,

(92). :

(93) " ( "

(94)

(95) ,

(96)

(97) 2

(98)

(99) 4 " 123I-m79 /.(

(100) sessment of CAN was observed.. 100.

(101)

(102) . .

(103)

(104) ,

(105).

(106)

(107)

(108) .

(109) ,:2, 16" $ ,. / " (

(110) ("

(111)

(112) )+

(113)

(114) , ,,

(115) , (" , " (./

(116) 2 (.

(117) 3"

(118)

(119) ,

(120). :7

(121)

(122) ./

(123) 2 "

(124)

(125) ,

(126). (.

(127) 3 O

(128) P

(129) , 2 (,. , /</

(130)

(131) "

(132) " "

(133) /(./

(134) :7

(135) 7)

(136)

(137) /

(138) ,( " 7

(139) ,(,. ,/

(140) /

(141) + "(

(142) $

(143) . .

(144) $

(145)

(146) (

(147) .

(148) , ,.

(149) " , .( )#+

(150) ,( "

(151) , 233C:36 Al "/

(152) " .

(153) "

(154) ,( "

(155) , " ,

(156) . ()*+

(157)

(158) " (

(159)

(160) $ ()4+ 2 .

(161) "

(162) ,( "

(163) , "(:F

(164) ,

(165) 2 *

(166)

(167) , ,, "

(168)

(169) !

(170) " ,. / "

(171)

(172)

(173) "2 increased risk of mortality and major cardiovascular events.125-129 However, although *

(174)

(175) " (4

(176) /$

(177) ,

(178) " "

(179)

(180)

(181) . (

(182)

(183) "

(184)

(185) /(,.

(186) /"(/ :130

(187) (,.

(188) /"

(189) $/ 2"( be assessed directly and noninvasively with 123I-m79,( " /.(,( clinical disorders, including diabetes.131-135 24"123I-m79,( " /.( ,.

(190) (,. ,/./

(191) 2 "

(192)

(193) 2:

(194)

(195)

(196) $/ "(

(197) $

(198) "

(199) .

(200) $

(201)

(202) * " 4$

(203) 123I-m79,( " /.(:. Methods . . ./

(204) 2

(205)

(206)

(207)

(208)

(209) " , ./

(210) "

(211) / / / </ : "

(212) ""

(213)

(214)

(215) #,( " .

(216) ,

(217) ,( "

(218) ,"4

(219) *:

(220) " "

(221)

(222) 2

(223)

(224) " (

(225)

(226)

(227) .(" <,

(228) " (./

(229) (

(230)

(231) ,

(232) "/ as insulin or oral hypoglycaemic agents.17

(233)

(234) " <,

(235) " (.

(236) 3 "

(237)

(238) ,

(239). , / 2 ,.

(240)

(241)

(242)

(243) !

(244) U$

(245) (,. ,: (,. ,/ 2 <,

(246) "

(247) 4

(248) U

(249) /

(250) gina.15#&

(251) 2

(252)

(253) = 2V

(254)

(255) ( .(

(256)

(257)

(258)

(259) ( (

(260) $ 8/

(261) ,

(262) 2 /! ,

(263) "/ 101.

(264) Chapter 8.

(265)

(266) " .

(267) $"

(268)

(269) W!2$

(270) ,( " /

(271) ,!

(272) ,

(273) !2$

(274)

(275) ,.

(276)

(277)

(278) O "

(279) "/$

(280) .,

(281) & "

(282)

(283) "

(284)

(285)

(286) #,( " .

(287) ,:7./

(288) 2 , ,( " .

(289) )

(290) "

(291) + 123I-m79 ,( " /.( 2.

(292) ,

(293) "

(294) $

(295)

(296) .

(297) $

(298)

(299) (,.

(300) /* ,.

(301) "

(302) .

(303) $

(304)

(305) *

(306)

(307) " (4:.

(308) U/ " ( 2

(309)

(310) .

(311) ,

(312) " "

(313)

(314) "

(315)

(316) :84

(317) Z( #9!

(318) " # , 2 .

(319) ,

(320) " 3!"( . )"

(321)

(322) "

(323) + 2

(324)

(325) /,![[,

(326) , )[[,77+:2

(327) $

(328) !

(329) "

(330)

(331) " .()#9+ 2

(332) "

(333) "

(334) ,

(335) " / ( ,

(336) " )

(337) " F @ " B+

(338) "

(339) $

(340) .,

(341) ( , !

(342) ,

(343) "

(344) $/ : 7, 2 .

(345) ,

(346) " @3\,

(347) O

(348)

(349)

(350) / .

(351) !

(352) "#,

(353) )9[D\\>9 . / ( .+ 2!

(354)

(355) (

(356) / . , :7,

(357) U/ 2.

(358) ,

(359) " D]\^ ]\.

(360) / "_\

(361) ">.

(362) / 61, 62* `

(363) /

(364) / 2..

(365) ":

(366) ",

(367) 2

(368)

(369) .

(370)

(371) "

(372) ,

(373) " !& 8 "$

(374) / !&$

(375) 2 2

(376)

(377)

(378)

(379) ":

(380) "

(381)

(382)

(383) #,( " .

(384) , "( 2 "

(385)

(386) " ,

(387) @+ 4"?3 3+

(388) /q#Fx_BC "D+

(389)

(390)

(391)

(392) " .

(393) 7 Z " 2 .!

(394) ,

(395) "

(396) .

(397) x@,, ;\,O

(398)

(399) !. 2 ,

(400)

(401) "

(402) #9""

(403)

(404) infusion.. !".

(405)

(406) " $ ,

(407) . ()*+

(408)

(409) $ ()4+2 ,

(410)

(411) ""

(412) . 2_" $

(413) Z

(414) &

(415) "

(416) "

(417) "2

(418) "

(419) #9:136, 137 1.. 4

(420) $

(421) @B\

(422) /$

(423)

(424) . 2.. 4""

(425)

(426) .

(427) ](

(428) .

(429) ,

(430) $

(431) @3\

(432) /$

(433)

(434) . 3.. 4" $,

(435) $

(436) . 4.. 7,,

(437) "

(438)

(439)

(440)

(441) .

(442) " ,

(443)

(444) ,

(445) . / :. 102.

(446)

(447) . <

(448) ,

(449)

(450) "

(451) "P

(452)

(453)

(454) ( ".

(455)

(456)

(457) 2

(458)

(459) .

(460) ". . / : * ./

(461) 2

(462)

(463)

(464)

(465) $ " Z

(466) 4

(467)

(468) ./ " 8.

(469) : /(.

(470)

(471) $

(472) ,

(473) "/

(474) $

(475) /

(476) 8(,

(477) )#+! "

(478)

(479)

(480) .

(481) )4+2

(482)

(483) ..

(484) "

(485) 2

(486)

(487)

(488)

(489) 4,

(490)

(491) ,

(492) :138, 139 Data analysis .

(493) #9

(494) "2

(495)

(496) (8

(497) " ( 2

(498) &.

(499)

(500)

(501) "

(502) $

(503) 2

(504)

(505) (

(506) ./

(507) :7

(508) "

(509)

(510) ,

(511)

(512) "2.

(513) ,

(514) " "

(515) "

(516) 2

(517)

(518) ":F

(519)

(520) $ / 4

(521)

(522) z

(523) $/ )+2

(524) ":1404""

(525)

(526) .

(527) 2

(528) $

(529) " ( /

(530) #!7/ )/

(531) ,

(532)

(533)

(534) 4!4

(535) $ "

(536) .

(537) /$

(538) (./ "

(539) &./ +:141

(540) { $ / | 2

(541) "

(542) /

(543)

(544) 4!4

(545) $ . 2

(546)

(547)

(548)

(549)

(550) 4!4

(551) $ "

(552) ,

(553) $

(554) :142 Im,

(555) "

(556)

(557)

(558)

(559) .

(560) ".2

(561) "

(562) {D\!@B/ | "

(563) <

(564) "

(565)

(566) 4!4

(567) $

(568) 3\!_\"$"

(569) " (

(570)

(571) 4!4

(572) $

(573) B!3B2

(574)

(575)

(576)

(577) <

(578) "

(579) .

(580)

(581) }.:

(582)

(583) 4!4

(584) $ ,

(585) 2(.

(586)

(587) 4!4

(588) $ 2

(589) /

(590) {D\! @B/ |:

(591)

(592)

(593) " ,

(594) 2

(595)

(596)

(597) "

(598) $ /

(599)

(600) _" $

(601) Z

(602) &

(603) :143/

(604) 2

(605)

(606)

(607) & "

(608) " , (2

(609)

(610)

(611)

(612) ,

(613)

(614) " 4"

(615) ,

(616) "

(617) 2

(618) /$

(619)

(620)

(621) .

(622) /

(623)

(624) & (

(625) ,.

(626) .

(627) / : "

(628)

(629)

(630) ( " .

(631)

(632)

(633) U

(634)

(635) D\,,2 3,

(636) O

(637) "2"

(638) <

(639) " as an abnormal heart rate response.144 *

(640)

(641) (42 <

(642) " "

(643) ,

(644) , " $

(645) Z

(646) &

(647) :2 ,

(648) ,

(649) 2

(650)

(651) "

(652) <

(653) "*. /$

(654) )#9!

(655) "" ,

(656) . (+"@

(657) *

(658) /$

(659) :145, 146. 123I-m#$

(660)

(661) .

(662) /

(663) 2

(664)

(665)

(666) "

(667) ( /"

(668) .

(669) " (,.

(670) /

(671) or other drugs known to interfere with m79.

(672) :( ".

(673) "123I was.

(674) "2 ", "

(675) / $

(676) . (]\,

(677)

(678)

(679) 123I-m79

(680) / : @;BU 123I-m79 )9#

(681)

(682) ~+2

(683)

(684) "]\

(685) " $

(686) ( 103.

(687) Chapter 8.

(688) :FO

(689)

(690) ,

(691) .

(692) /

(693) . ,

(694)

(695)

(696) 2

(697)

(698) U

(699) " "

(700) " 3B] & 3B] , &:

(701)

(702) O

(703) D]\^ # "( 2 U

(704) " "

(705) !

(706) ",,,

(707) )9[D\\>9 . / ( .+)_>

(708) . DB

(709) >.

(710) / @3;&@3;, &+:4

(711) .

(712) . "# "

(713) 2

(714)

(715) U

(716) " .. &,

(717) (_ . !

(718) / :. ,

(719)

(720) "2

(721)

(722)

(723) U..

(724) "2 . 2!

(725)

(726) (!

(727) / . , ". U/ 2

(728)

(729) .

(730) ,

(731) "2 @BC

(732)

(733) (2" 2

(734)

(735)

(736) "

(737) @B[

(738) . .

(739) 123I..

(740) Planar images # ()@B,. !

(741) / +"

(742) )_! "

(743) (

(744) "+. ,

(745) 2

(746)

(747) .

(748)

(749) " "

(750)

(751) ,

(752)

(753)

(754) ! !,

(755) "/, / )4+:

(756) . m79 ,

(757) 2

(758)

(759) (8

(760) "

(761)

(762)

(763) )47+

(764)

(765) .

(766) / " 2 .

(767)

(768)

(769) :

(770)

(771)

(772) 472"2,. ( $

(773)

(774)

(775) O$

(776)

(777) :

(778) "

(779) 47 $

(780)

(781) ..

(782) ,

(783) "/," ..

(784) ,2

(785)

(786)

(787) "

(788)

(789)

(790)

(791) "

(792) :

(793) 4 $

(794)

(795) .

(796) .&

(797) 2

(798) "

(799)

(800) ( " "

(801) (

(802) " ,

(803) : O

(804)

(805) /

(806) .( "

(807) ( 123I, early and "

(808) (

(809) "4$

(810) 2

(811)

(812)

(813)

(814) " ,.

(815)

(816) ,( " 2 / )%4+ of m79. 2= %4

(817) (

(818) !

(819) (,

(820) "/, "

(821) (

(822) "

(823) !"

(824) (

(825) " ,

(826) "/, >

(827) (

(828) !

(829) (,

(830) "/, &@\\C:

(831) , $

(832)

(833) $"

(834)

(835) ..

(836)

(837)

(838) "

(839) (

(840) "79,

(841) )"

(842) "

(843) $

(844) "4"%4+ /</ , "

(845) (

(846) "4"%42

(847)

(848) "

(849) <

(850) " 2

(851) @:;"

(852) 3BC

(853) .

(854) /$

(855) (:147, 148 #,

(856) ,. , ) , 8

(857) " @\\C+2

(858)

(859)

(860) "

(861) ,!U/ /$

(862) "$

(863) .

(864) / :

(865) "

(866) (

(867) " ,( " # ,

(868) 2

(869)

(870) "$"

(871) " @E

(872) ments and each segment was evaluated in consensus by two expert observers, using _!. (

(873) ,)\=AE\C

(874) .

(875) @=B\!E\C

(876) .

(877) 3=D\!B\C

(878) .

(879) D= ?D\C

(880) .

(881) +:66, 85 As a result, the summed score for each "( "

(882)

(883) /. (

(884) ,\ B@)@E&D+:

(885) "

(886)

(887)

(888) )+2

(889) "

(890) , . "

(891)

(892)

(893) :

(894) 2 $

(895)

(896) " .

(897)

(898)

(899)

(900) "

(901)

(902) $

(903) ",( ",:

(904) .

(905)

(906)

(907) "

(908)

(909) $/

(910) q2

(911) " . 2=)>B@,&,,

(912) @E&D&@\\:

(913) "

(914) "( (,

(915) 104.

(916)

(917) . A@;2 "

(918)

(919) " , V2

(920)

(921)

(922) " _!. (

(923) , )

(924) "

(925)

(926) "(+ A@D2 "

(927) "

(928)

(929) " , :149 Next, the. / "

(930)

(931) 2

(932) $

(933) " "

(934) 8

(935) "

(936) .

(937)

(938)

(939) . : 7 ""/ ./

(940) 2

(941)

(942)

(943) 8

(944) " $ @ "

(945)

(946) .

(947) " @

(948) )

(949)

(950) $

(951) + $x3"

(952)

(953) "P

(954) (

(955) "

(956) "79.

(957) : * assessed by. 123I-m79/.(2"

(958) <

(959) ". , =4?@:; %A3BC . A@D:.

(960)

(961)

(962)

(963)

(964) /2

(965)

(966)

(967) &.

(968)

(969) ",

(970) ".

(971)

(972)

(973) : / $

(974) 2

(975)

(976)

(977) &.

(978)

(979) " ,

(980) ) "" "

(981) $/ +: // (

(982) 2

(983)

(984) .

(985) ,

(986) " O2

(987) )$

(988) @3:\ 7 7 ~+" O2

(989) )

(990) (

(991) ,

(992)

(993)

(994) ]:@3 ( * ~=7/

(995) 7:+:!$

(996) ?\:\B 2 "

(997)

(998) " //. (< :. Results F ,

(999)

(1000) ( @@\

(1001) /$

(1002) ./

(1003) 2 , #.

(1004) "

(1005) 2

(1006)

(1007) "

(1008) /<

(1009) ""$

(1010) 123I-m79/.(:

(1011)

(1012) 33)3\C+./

(1013) 2

(1014)

(1015)

(1016) & "

(1017) ""

(1018) ,.

(1019)

(1020) "

(1021) )@D+ . 79,

(1022) U ()[+:

(1023) < ./

(1024) . . /

(1025) " ;;./

(1026) )B],

(1027)

(1028) BD@\(

(1029) +:

(1030) ./

(1031)

(1032) /

(1033) 2

(1034) @:

(1035) ,

(1036) "/ "

(1037)

(1038) 2[:; ;:3(

(1039) :

(1040) ./

(1041) 2

(1042)

(1043) /!"

(1044) /

(1045) .()]@C+:# >42

(1046) "DBC"3@C ./

(1047) :2

(1048) (!

(1049) ./

(1050) " ,. / of diabetes, such as peripheral neuropathy and/or peripheral vascular disease.. Cardiac autonomic neuropathy assessed by HRV

(1051) ;;./

(1052) *2 <

(1053) " "

(1054) ,

(1055) , " $

(1056) Z

(1057) &

(1058) : ()D_C+

(1059)

(1060) ./

(1061) "x@ , " $

(1062) Z

(1063) &

(1064) :2

(1065) (! )3EC+./

(1066) 2

(1067)

(1068) "

(1069)

(1070) " $

(1071) x3 ,

(1072) "2

(1073)

(1074)

(1075) 8

(1076) "*. /$

(1077) : 105.

(1078) Chapter 8. Table 1. /

(1079)

(1080) / ;;(,. ,/./

(1081) 2 "

(1082)

(1083) (.

(1084) 3: between parentheses indicate percentages. Variables Male

(1085) )(

(1086) +. %&& B])]_+ 53±10.

(1087)

(1088) !

(1089)

(1090) " / )(

(1091) +. 9.8±8.2.

(1092) /,

(1093) " "

(1094)

(1095) )(

(1096) +. 44±12. HbA1C. 7.4±1.6. Treatment Oral/Insulin Oral and Insulin Peripheral vascular disease/peripheral neuropathy Peripheral vascular and neuropathy. B_)]@+>3@)3_+ @@)@D+ [)@\+>@[)33+ @@)@D+. "(,"

(1097) &)>,2+. 29.2±5.7. % ,

(1098)

(1099)

(1100) ),+. 103±15.0. Hypertension. _E)BD+. Hypercholesterolemia. _])B3+. F, ( ( . B3)B[+. Current Smoking. @3)@_+.

(1101) "/ Aspirin # >4 /. @;)3@+ D@)DB+>@;)3@+ _B)B@+.

(1102)

(1103) ),, > +. 4.9±1.1. qq),, > +. 3.2±.1.1. q),, > +. 1.4±0.6.

(1104)

(1105) >q/. 3.8±1.3. (

(1106) "

(1107) ),, > +. 2.0±1.2.

(1108) /

(1109) ),, > +. 78.5±20.0. ~

(1110) ,!

(1111) /

(1112) /. 12.4±32.8. 4),> +. 8.3±5.8. . . .

(1113) @)> +. 1.4±0.30. . . .

(1114) )> +. 0.9±0.30. F

(1115) )> +. 3.9±0.90. #

(1116) $

(1117) /

(1118) 8(,

(1119) V4

(1120)

(1121)

(1122) .

(1123) V (

(1124) ("

(1125)

(1126) V4

(1127) /$

(1128) .

(1129) Vq !"

(1130) ( . .

(1131) Vqq 2!"

(1132) ( . .

(1133) :. 106.

(1134)

(1135) . Cardiac autonomic neuropathy assessed by 123I-mIBG

(1136) ;;./

(1137) DE./

(1138) )_3C+" , 123I-m79 "(:7

(1139)

(1140) , B@./

(1141) )B;C+

(1142) 123I-m79 "(2 , :

(1143)

(1144) B@./

(1145) 33./

(1146) )_DC+ " @

(1147) , , 123I-m79 "(V

(1148)

(1149) , D\ ./

(1150) )BEC+"x3

(1151) :7

(1152) ;;./

(1153) D])_@C+./

No results found